Parvus Therapeutics Inc.
Profile
Mailing Address: Suite 119, 3553 -31st Street NW
Calgary, Alberta
T2L 2K7
Head Office Address: Suite 119, 3553 - 31st Street NW
Calgary, Alberta
T2L 2K7
Contact Name: Jord Cowan Principal Regulator: Non-Reporting Issuer
Business e-mail address: jcowan@parvustherapeutics.com Short Form Prospectus Issuer: No
Telephone Number: 403 708-3401 Reporting Jurisdictions: Non-Reporting Issuer
Fax Number: Stock Exchange: N/A
Date of Formation: Apr 21 2009 Stock Symbol:
Jurisdiction Where Formed: Alberta Auditor: N/A
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: Transfer Agent:
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents